PODD
Insulet CorporationNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$11.06B
P/E Ratio
37.29
EPS
$4.28
Beta
1.13
52W High
$354.88
52W Low
$140.63
50-Day MA
$174.15
200-Day MA
$263.83
Dividend Yield
—
Profit Margin
10.40%
Forward P/E
24.69
PEG Ratio
1.35
About Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.
Fundamentals
| Revenue (TTM) | $2.90B |
| Gross Profit (TTM) | $2.06B |
| EBITDA | $602.00M |
| Operating Margin | 16.00% |
| Return on Equity | 23.00% |
| Return on Assets | 9.74% |
| Revenue/Share (TTM) | $41.28 |
| Book Value | $18.81 |
| Price-to-Book | 8.15 |
| Price-to-Sales (TTM) | 3.81 |
| EV/Revenue | 3.82 |
| EV/EBITDA | 19.64 |
| Quarterly Earnings Growth (YoY) | 159.00% |
| Quarterly Revenue Growth (YoY) | 33.90% |
| Shares Outstanding | $69.27M |
| Float | $68.99M |
| % Insiders | 0.33% |
| % Institutions | 105.55% |
Historical Volatility
HV 10-Day
56.51%
HV 20-Day
51.10%
HV 30-Day
71.65%
HV 60-Day
53.68%
HV Rank
100.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($243.78 target)
4
Strong Buy17
Buy3
HoldMore HEALTHCARE Stocks
Data last updated: 6/11/2026